Womens Health

GLP-1 Medications and Thyroid Conditions in Women: What You Need to Know

If you're a woman considering GLP-1 medication for weight loss but have a thyroid condition, you're not alone in wondering whether these treatments are safe for you. Thyroid disorders affect women at significantly higher rates than men, and many women navigating weight management also manage hypothyroidism, Hashimoto's disease, or a history of thyroid nodules. The good news is that for most people, GLP-1 medications can be used safely alongside thyroid conditions, but there are important considerations to understand before starting treatment.

Understanding GLP-1 Medications and How They Work

GLP-1 receptor agonists like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) are medications that mimic a natural hormone in your body called glucagon-like peptide-1. This hormone helps regulate blood sugar levels and appetite, making these medications effective for both diabetes management and weight loss.

These medications work by slowing digestion, reducing appetite, and helping your body respond better to insulin. They've become increasingly popular because of their significant effectiveness in helping people achieve meaningful weight loss when combined with lifestyle changes.

The Thyroid Connection: What Women Need to Know

Thyroid conditions are far more common in women than men, with women being five to eight times more likely to develop thyroid problems. The thyroid gland produces hormones that regulate metabolism, energy levels, and weight, which is why thyroid disorders often make weight management particularly challenging.

When it comes to GLP-1 medications and thyroid health, there are two main considerations: existing thyroid conditions like hypothyroidism or Hashimoto's disease, and a rare but important precaution regarding a specific type of thyroid tumor.

Hypothyroidism and Hashimoto's Disease

If you have hypothyroidism or Hashimoto's thyroiditis, you can generally use GLP-1 medications safely. These conditions involve an underactive thyroid that doesn't produce enough thyroid hormone, which is typically managed with levothyroxine or similar medications.

GLP-1 medications don't directly interfere with thyroid hormone production or thyroid medication effectiveness. However, because GLP-1s slow gastric emptying (how quickly food moves through your stomach), they may affect how your body absorbs thyroid medication if taken too close together.

The Medullary Thyroid Cancer Precaution

The most important thyroid-related consideration with GLP-1 medications is a contraindication for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).

This precaution exists because animal studies showed an increased risk of thyroid C-cell tumors in rodents exposed to GLP-1 medications. It's crucial to understand that this has not been observed in humans during clinical trials and post-market surveillance, but the FDA requires a black box warning out of an abundance of caution.

MTC is a rare form of thyroid cancer, accounting for only about 3-4% of all thyroid cancers. The much more common types of thyroid cancer, papillary and follicular thyroid cancers, are not contraindications for GLP-1 therapy.

Thyroid Nodules: A Common Concern for Women

Many women discover they have thyroid nodules during routine imaging or ultrasounds. Thyroid nodules are incredibly common, especially as we age, and the vast majority are benign (non-cancerous).

Having benign thyroid nodules does not prevent you from using GLP-1 medications. However, it's important that your healthcare provider knows about any thyroid nodules before prescribing GLP-1 therapy, and that you've had appropriate evaluation to rule out medullary thyroid carcinoma if there's any concern.

Optimizing Both Thyroid and GLP-1 Medications

If you have hypothyroidism and are taking thyroid hormone replacement, here are some practical considerations for using GLP-1 medications effectively:

When GLP-1 Medications Are Not Recommended

You should not use GLP-1 medications if you have:

These are absolute contraindications, meaning GLP-1 therapy should be avoided entirely in these situations.

Gender-Specific Considerations

Women face unique challenges when it comes to both thyroid health and weight management. Hormonal fluctuations throughout the menstrual cycle, during pregnancy, and in perimenopause and menopause can affect both thyroid function and weight. Women with thyroid conditions may find weight loss particularly difficult, even when their thyroid levels are well-controlled with medication.

While men can also develop thyroid conditions and benefit from GLP-1 therapy, the intersection of these issues is far more common in women. If you're a woman dealing with both thyroid concerns and weight management challenges, you're navigating a complex situation that deserves individualized medical attention.

Questions to Ask Your Healthcare Provider

Before starting GLP-1 medication, have an open conversation with your doctor about:

From the Ozari Care Team

If you have well-controlled hypothyroidism and are considering GLP-1 therapy, continue taking your thyroid medication consistently every morning on an empty stomach, at least 30-60 minutes before food or your GLP-1 injection. As you lose weight, your thyroid medication requirements may decrease, so we recommend checking your TSH levels every 3-4 months during active weight loss. Most of our patients with thyroid conditions do beautifully on GLP-1 therapy when both conditions are monitored appropriately.

At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.

Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 26, 2026